title: Protein synthesis in presynaptic endings from squid brain: modulation by calcium ions.
abstract: Previous biochemical, autoradiographic, and ultrastructural data have shown that, in the synaptosomal fraction of the squid optic lobe, protein synthesis is largely due to the presynaptic terminals of the retinal photoreceptor neurons (Crispino et al. [1993a] Mol. Cell. Neurosci. 4:366-374; Crispino et al. [1993b] J. Neurochem. 61:1144-1146; Crispino et al. [1997] J. Neurosci. 17:7694-7702). We now report that this process is close to its maximum at the basal concentration of cytosolic Ca++, and is markedly inhibited when the concentration of this ion is either decreased or increased. This conclusion is supported by the results of experiments with: 1) compounds known to increase the level of cytosolic Ca++, such as A23187, ionomycin, thapsigargin, and caffeine; 2) compounds sequestering cytosolic calcium ions such as BAPTA-AM; and 3) agents that block the role of Ca++ as second messenger, such as TFP and W7, which inhibit calmodulin, and calphostin, which inhibits protein kinase C. We conclude that variations in the level of cytosolic Ca++ induced in presynaptic terminals by neuronal activity may contribute to the modulation of the local synthesis of protein.
authors.affiliation: Instituto de Investigaciones Biologicas Clemente Estable, Montevideo, Uruguay.
authors.forename: J C
authors.initials: JC
authors.lastname: Benech
authors.forename: M
authors.initials: M
authors.lastname: Crispino
authors.forename: B B
authors.initials: BB
authors.lastname: Kaplan
authors.forename: A
authors.initials: A
authors.lastname: Giuditta
mesh_terms: D000818:Animals; D001921:Brain / Q000378:metabolism; D002110:Caffeine / Q000494:pharmacology; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology / Q000502:physiology*; D003600:Cytosol / Q000378:metabolism; D049832:Decapodiformes; D004533:Egtazic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D015759:Ionomycin / Q000494:pharmacology; D007700:Kinetics; D008274:Magnesium / Q000494:pharmacology; D009281:Naphthalenes / Q000494:pharmacology; D009419:Nerve Tissue Proteins / Q000096:biosynthesis*; D017729:Presynaptic Terminals / Q000187:drug effects / Q000378:metabolism*; D013449:Sulfonamides / Q000494:pharmacology; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism; D019284:Thapsigargin / Q000494:pharmacology; D014268:Trifluoperazine / Q000494:pharmacology
chemical_list: D009281:Naphthalenes; D009419:Nerve Tissue Proteins; D013449:Sulfonamides; C061465:calphostin complex; C070379:1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester; D014268:Trifluoperazine; D000001:Calcimycin; D002110:Caffeine; D004533:Egtazic Acid; D015759:Ionomycin; C017967:W 7; D019284:Thapsigargin; D008274:Magnesium; D002118:Calcium